MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.radonc.2024.110311

Медицинская библиотека · Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology · 2024

Efficacy of metastatic lesion radiotherapy in patients with metastatic nasopharyngeal carcinoma: A multicenter retrospective study.

Liu Yang, Ma Jie, Zeng Xiao-Yi, Zuo Zhi-Chao, Chen Rui-Zhong, Li Xiao-Yu, Liang Zhong-Guo, Chen Kai-Hua, Pan Xin-Bin, Pei Su, Yu Bin-Bin, Li Ling, Qu Song, Yang Yun-Li, Zhu Xiao-Dong

СтатьяМногоцентровое исследованиеПеревод пока не подготовлен

Аннотация

OBJECTIVE

We investigated the efficacy of metastatic lesion radiotherapy (MLRT) in patients with metastatic nasopharyngeal carcinoma (mNPC).

MATERIALS AND

METHODS

Patients with mNPC from three institutions were included in this study. Propensity score matching (PSM) was employed to ensure comparability between patient groups. Overall survival (OS) rates were assessed using the Kaplan-Meier method and compared using the log-rank test. Prognostic factors were identified using univariate and multivariate Cox hazard analyses. Subgroup analyses were conducted to assess the effects of MLRT on specific patient populations.

RESULTS

We analyzed data from 1157 patients with mNPC. Patients who received MLRT had significantly better OS than those who did not, both in the original (28 vs. 21 months) and PSM cohorts (26 vs. 23 months). MLRT was identified as an independent favorable predictor of OS in multivariate analyses, with hazard ratios of 0.67. The subgroup analysis results indicated that radiotherapy effectively treated liver, lung, and bone metastatic lesions, particularly in patients with a limited tumor burden. Higher total radiation doses of MLRT (biologically effective dose (BED) ≥ 56 Gy) were associated with improved OS, while neither radiation technique nor dose fractionation independently influenced prognosis.

CONCLUSIONS

MLRT offers survival advantages to patients diagnosed with mNPC. Patients with limited metastatic burden derive the most benefit from MLRT, and the recommended regimen for MLRT is a minimum BED of 56 Gy for optimal outcomes.

Для цитирования: Liu Yang, Ma Jie, Zeng Xiao-Yi, Zuo Zhi-Chao, Chen Rui-Zhong, Li Xiao-Yu, Liang Zhong-Guo, Chen Kai-Hua, Pan Xin-Bin, Pei Su, Yu Bin-Bin, Li Ling, Qu Song, Yang Yun-Li, Zhu Xiao-Dong. Efficacy of metastatic lesion radiotherapy in patients with metastatic nasopharyngeal carcinoma: A multicenter retrospective study.. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2024. DOI: 10.1016/j.radonc.2024.110311.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.